Synergistic Multi-Channel RF Ablation System with Integrated AI, IoT, Blockchain, and Advanced Materials
Legal Citation
Summary of the Inventive Concept
The invention integrates multi-channel RF ablation with AI, IoT, blockchain, and advanced materials to create a more effective and efficient treatment system for cardiac arrhythmias, offering real-time monitoring, personalized treatment, and enhanced safety.
Background and Problem Solved
The original patent described a multi-channel RF ablation method, but it lacked real-time monitoring and adaptation capabilities, limited its applicability and effectiveness. The new inventive concept addresses these limitations by incorporating synergistic technologies to provide a more comprehensive and adaptive treatment system.
Detailed Description of the Inventive Concept
The system consists of a control signal generator, an ablation signal generator, a combiner, and one or more of the following modules: AI-based monitoring, IoT-enabled sensors, blockchain-based data storage, and new materials-based electrodes. The AI module analyzes the control signals and adjusts the ablation signals in real-time, while the IoT sensors monitor the subject's physiological response and provide feedback for adjustment. The blockchain module securely stores and manages the subject's treatment data, ensuring data integrity and confidentiality. The new materials-based electrodes provide enhanced tissue contact and reduced thermal spread, improving treatment outcomes.
Novelty and Inventive Step
The new inventive concept combines the original multi-channel RF ablation method with distinct technologies, creating a synergistic system that provides real-time monitoring, personalized treatment, and enhanced safety. The integration of AI, IoT, blockchain, and advanced materials constitutes a novel and non-obvious improvement over the original patent.
Alternative Embodiments and Variations
Alternative embodiments may include varying the AI algorithm, using different IoT sensor configurations, or incorporating other advanced materials for electrodes. Variations may also include adapting the system for other medical applications, such as cancer treatment or pain management.
Potential Commercial Applications and Market
The Synergistic Multi-Channel RF Ablation System has significant commercial potential in the medical device industry, particularly in the cardiac arrhythmia treatment market. The system's real-time monitoring and adaptation capabilities, combined with its enhanced safety features, make it an attractive solution for hospitals and medical centers.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B18/1206 |
| A | A61 | A61B18/1492 |
| A | A61 | A61B2018/00351 |
| A | A61 | A61B2018/00577 |
| A | A61 | A61B2018/00702 |
| A | A61 | A61B2018/00732 |
| A | A61 | A61B2018/00767 |
| A | A61 | A61B2018/00791 |
| A | A61 | A61B2018/00827 |
| A | A61 | A61B2018/00875 |
| A | A61 | A61B2018/00892 |
| A | A61 | A61B2018/128 |
| A | A61 | A61B2018/1273 |
Original Patent Information
| Patent Number | US 11,857,245 |
|---|---|
| Title | Multi-channel RF ablation |
| Assignee(s) | Biosense Webster (Israel) Ltd. |